ARTICLE | Clinical News

rhITF Intestinal Trefoil Factor: Phase I data

July 7, 2008 7:00 AM UTC

In a double-blind, placebo-controlled Phase I trial in 10 healthy volunteers, a single 12 mg dose of rhITF increased ITF immunoreactivity on the adherent mucus in the oral cavity by >500 fold, with a ...